Kolexia
Khayath Naji Pneumologie
Khayath Naji
Pneumologie
Hôpital Civil
Strasbourg, France
90 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Asthme Hypersensibilité Maladies pulmonaires Broncho-pneumopathie chronique obstructive Aspergillose Aspergillose pulmonaire Aspergillose bronchopulmonaire allergique Inflammation Rhinite allergique

Collaborateurs

Voir plus
Marcot Christophe
Marcot Christophe
Hôpital Civil, Strasbourg, France
Deck Carmen
Deck Carmen
Ch Intercommunal De La Lauter, Wissembourg, France
Favre-Metz Carine
Favre-Metz Carine
Hôpital Civil, Strasbourg, France
Melscoet Lise
Melscoet Lise
Chirc Site Redon, Redon, France

Industries

Voir plus
B3TSI
65 collaboration(s)
Dernière en 2023
P\S\L Group Services
42 collaboration(s)
Dernière en 2023
A+A
32 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
32 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants 12 Years of Age and Older With Asthma: A Randomized, Double-blind, Parallel Group, Multi-center Study to Evaluate the Long-term Safety of Salbutamol Rescue Medication When Administered Via Metered Dose Inhalers Containing the Propellant HFA-152a or Reference HFA-134a
Essai Clinique (GSK)   08 février 2024
ARPEGES: Improvement to Perform Thoracocentesis After a Specific Training in Medical Students With the Supervised Use of an Augmented Reality Simulator
Essai Clinique (CHU Strasbourg)   12 janvier 2024
Description des patients présentant une broncho-pneumopathie chronique obstructive traités par biothérapie au CHU de Strasbourg
28e Congrès de Pneumologie de Langue Française   01 janvier 2024
BENRAPRED: Predictive Signature of Benralizumab Response
Essai Clinique (CHU Nantes)   22 décembre 2023
Improvement in severe asthma patients receiving biologics and factors associated with persistent insufficient control: a real-life national study.
Therapeutic advances in respiratory disease   16 novembre 2023
Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology   13 septembre 2023
Allergenic and chemical pollutants of indoor environments and asthma: Characterization, assessment and eviction.
Revue des maladies respiratoires   28 juin 2023
Description des asthmatiques échappant aux biothérapies aux hôpitaux universitaires de Strasbourg : étude monocentrique
18e Congrès Francophone d'Allergologie   01 avril 2023
Induction of immunosuppressive CD39 but not the trafficking C-C chemokine receptor 4 on Treg during LAR in mite allergic asthma.
Allergy   02 mars 2023
Severe non-atopic asthma: omalizumab can reduce severe asthma exacerbations.
The Journal of asthma : official journal of the Association for the Care of Asthma   11 août 2022